Methods of Making High Enantioselective Secondary Alcohols
AssigneeObi Pharma, Inc.
InventorsCheng-Der Tony Yu, Yih-Huang Hsieh, Shu-Yi Lin, Chin-Sheng Chao, Yin-Cheng Hsieh, Ming-Tain Lai
Life of this patent
Estimating the term…
Loading patent…
AssigneeObi Pharma, Inc.
InventorsCheng-Der Tony Yu, Yih-Huang Hsieh, Shu-Yi Lin, Chin-Sheng Chao, Yin-Cheng Hsieh, Ming-Tain Lai
Estimating the term…
A new process to synthesis of compound OBI-3424 R-form and S-form products is provided. The “R-form” compound OBI-3423 was first synthesized with 48% overall yield from compound OBI-3424-5 by installation of the labile phosphate motif at later stage. The stereo chemistry is established by 5 steps chemo-enzyme combination synthesis to afford 99% optical purity. After then, the “S-form” compound OBI-3424 is prepared with improving overall yield of 54% from compound OBI-3424-5. The stereo chemistry is established by 4 steps combination of chemo-enzyme synthesis with excellent optical purity of 99%.
A method for preparing a compound of Formula 1, comprising:
A method for preparing a compound of Formula 1, comprising:
A method for preparing a compound of Formula 4, comprising:
A method for preparing a compound of Formula 4, comprising:
A process for improving a yield or optical purity of compound (R)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N′-bis(ethylene)phosphoramidate
Dependencies are inferred from the claim text.